Indivior Pharmaceuticals (INDV) Price to Book (2021 - 2026)

Indivior Pharmaceuticals has reported Price to Book for 6 years, with the latest figure at 23.28 in Q2 2026.

• On a quarterly basis, Price to Book fell 225.31% year-over-year to 23.28 in Q2 2026; TTM through Jun 2026 was 23.28, a 225.31% decrease from a year earlier, with the FY2025 full-year figure at 45.79, down 895.88% from the prior year.
• Price to Book was 23.28 for Q2 2026 at Indivior Pharmaceuticals, up from 25.81 in the prior quarter.
• The five-year high for Price to Book was 4.15 in Q3 2024, with the low at 197.9 in Q4 2022.
• Average Price to Book over 5 years is 30.38, with a median of 12.94 recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Price to Book slumped 1053.01% in 2022, then surged 94.27% in 2023.
• Over 5 years, Price to Book stood at 197.9 in 2022, then soared by 94.27% to 11.33 in 2023, then jumped by 59.42% to 4.6 in 2024, then slumped by 895.88% to 45.79 in 2025, then surged by 49.16% to 23.28 in 2026.
• The last three Price to Book figures came in at 23.28 (Q2 2026), 25.81 (Q1 2026), and 45.79 (Q4 2025), per Business Quant data.